CD44-deficiency attenuates the immunologic responses to LPS and delays the onset of endotoxic shock-induced renal inflammation and dysfunction

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Rampanelli, Elena ^a   Dessing, Mark C ^a   Claessen, Nike ^a   Teske, Gwendoline J D ^a   Joosten, Sander P J ^a   Pals, Steven T ^a   Leemans, Jaklien C ^a   Florquin, Sandrine ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY INJURY; ANIMALS; ANTIGENS, CD44; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; SHOCK, SEPTIC; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84893434475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084479     Document Type: Article

References (46)

1. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS et al. (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273: 117-123. doi:10.1001/jama.1995.03520260039030. PubMed: 7799491.
2. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420: 885-891. doi:10.1038/nature01326. PubMed: 12490963.
3. Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351: 159-169. doi:10.1056/NEJMra032401. PubMed: 15247356.
4. Remick DG, Newcomb DE, Bolgos GL, Call DR (2000) Comparison of the mortality and inflammatory response of two models of sepsis: Lipopolysaccharide vs. Cecal ligation and puncture. Shock 13: 110-116. doi:10.1097/00024382- 200013020-00004. PubMed: 10670840.
5. Knotek M, Rogachev B, Wang W, Ecder T, Melnikov V et al. (2001) Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59: 2243-2249. doi:10.1046/j.1523- 1755.2001.00740.x. PubMed: 11380827. (Pubitemid 32467617)
6. Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N et al. (2007) Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol 292: F261-F268. PubMed: 16926442. (Pubitemid 46115929)
7. Ponta H, Sherman L, Herrlich PA (2003) CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45. doi:10.1038/nrm1004. PubMed: 12511867. (Pubitemid 36077255)
8. Puré E, Cuff CA (2001) A crucial role for CD44 in inflammation. Trends Mol Med 7: 213-221. doi:10.1016/S1471-4914(01)01963-3. PubMed: 11325633. (Pubitemid 32822893)
9. Rouschop KM, Roelofs JJ, Sylva M, Rowshani AT, Ten Berge IJ et al. (2006) Renal expression of CD44 correlates with acute renal allograft rejection. Kidney Int 70: 1127-1134. doi:10.1038/sj.ki.5001711. PubMed: 16871244. (Pubitemid 44344084)
10. Rouschop KM, Roelofs JJ, Claessen N, da Costa Martins P, Zwaginga JJ et al. (2005) Protection against renal ischemia reperfusion injury by CD44 disruption. J Am Soc Nephrol 16: 2034-2043. doi:10.1681/ASN.2005010054. PubMed: 15901765.
11. Florquin S, Nunziata R, Claessen N, van den Berg FM, Pals ST et al. (2002) CD44 expression in IgA nephropathy. Am J Kidney Dis 39: 407-414. doi:10.1053/ajkd.2002.30563. PubMed: 11840384. (Pubitemid 34174266)
12. Leemans JC, Florquin S, Heikens M, Pals ST, van der Neut R et al. (2003) CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis. J Clin Invest 111: 681-689. doi:10.1172/JCI200316936. PubMed: 12618522. (Pubitemid 36278586)
13. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H et al. (2007) Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 282: 18265-18275. doi:10.1074/jbc.M606352200. PubMed: 17400552. (Pubitemid 47100227)
14. Vachon E, Martin R, Kwok V, Cherepanov V, Chow CW et al. (2007) CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages. Blood 110: 4492-4502. doi:10.1182/blood-2007- 02-076539. PubMed: 17827392. (Pubitemid 351377816)
15. Shi X, Leng L, Wang T, Wang W, Du X et al. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25: 595-606. doi:10.1016/j.immuni.2006.08.020. PubMed: 17045821. (Pubitemid 44529040)
16. Hollingsworth JW, Li Z, Brass DM, Garantziotis S, Timberlake SH et al. (2007) CD44 regulates macrophage recruitment to the lung in lipopolysaccharide- induced airway disease. Am J Respir Cell Mol Biol 37: 248-253. doi:10.1165/rcmb.2006-0363OC. PubMed: 17446529. (Pubitemid 47255008)
17. Hasan Z, Palani K, Rahman M, Thorlacius H (2011) Targeting CD44 expressed on neutrophils inhibits lung damage in abdominal sepsis. Shock 35: 567-572. doi:10.1097/SHK.0b013e3182144935. PubMed: 21330943.
18. Wang Q, Teder P, Judd NP, Noble PW, Doerschuk CM (2002) CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am J Pathol 161: 2219-2228. doi:10.1016/S0002-9440(10)64498- 7. PubMed: 12466136. (Pubitemid 35434866)
19. van der Windt GJ, van 't Veer C, Florquin S, van der Poll T (2010) CD44 deficiency is associated with enhanced Escherichia coli-induced proinflammatory cytokine and chemokine release by peritoneal macrophages. Infect Immun 78: 115-124. doi:10.1128/IAI.00949-09. PubMed: 19901064.
20. Rouschop KM, Sylva M, Teske GJ, Hoedemaeker I, Pals ST et al. (2006) Urothelial CD44 facilitates Escherichia coli infection of the murine urinary tract. J Immunol 177: 7225-7232. PubMed: 17082640. (Pubitemid 44715091)
21. Rittirsch D, Flierl MA, Ward PA (2008) Harmful molecular mechanisms in sepsis. Nature reviews 8: 776-787. doi:10.1038/nri2402. PubMed: 18802444.
22. Weischenfeldt J, Porse B (2008) Bone marrow-derived macrophages (BMM): Isolation and applications. CSH protocols 2008: pdb prot5080.
23. Rampanelli E, Rouschop K, Teske GJ, Claessen N, Leemans JC, et al. (2013) CD44v3-v10 reduces the pro-fibrotic effects of TGF-β1 and attenuates tubular injury in the early stage of chronic obstructive nephropathy. American journal of phyysiology. PMID:24026183.
24. Kers J, Xu-Dubois YC, Rondeau E, Claessen N, Idu MM et al. (2010) Intragraft tubular vimentin and CD44 expression correlate with long-term renal allograft function and interstitial fibrosis and tubular atrophy. Transplantation 90: 502-509. doi:10.1097/00007890-201007272-00937. PubMed: 20588206.
25. Rouschop KM, Sewnath ME, Claessen N, Roelofs JJ, Hoedemaeker I et al. (2004) CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 15: 674-686. doi:10.1097/01.ASN. 0000115703.30835.96. PubMed: 14978169. (Pubitemid 38294797)
26. Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91: 221-264. doi:10.1152/physrev.00052.2009. PubMed: 21248167.
27. de Geus HR, Betjes MG, Bakker J (2012) Biomarkers for the prediction of acute kidney injury: A narrative review on current status and future challenges. Clin Kidney J 5: 102-108. doi:10.1093/ckj/sfs008. PubMed: 22833807.
28. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13: 816-825. doi:10.1038/sj.cdd.4401850. PubMed: 16410796.
29. Zoller M (2011) Cd44: Can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11: 254-267.
30. Li X, Tupper JC, Bannerman DD, Winn RK, Rhodes CJ et al. (2003) Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect Immun 71: 4414-4420. doi:10.1128/IAI.71.8.4414-4420.2003. PubMed: 12874320. (Pubitemid 36919907)
31. Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP et al. (2008) Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev 22: 1490-1500. doi:10.1101/gad.1662308. PubMed: 18519641. (Pubitemid 351793083)
32. Khan S, Choi RJ, Shehzad O, Kim HP, Islam MN et al. (2013) Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling in in vitro and in vivo experimental models. J Ethnopharmacol 145: 626-637. PubMed: 23237934.
33. Kim HG, Yoon DH, Lee WH, Han SK, Shrestha B et al. (2007) Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-kappaB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophage. J Ethnopharmacol 114: 307-315. doi:10.1016/j.jep.2007.08.011. PubMed: 17936530. (Pubitemid 350026213)
34. Murphy SL, Xu J, Kochanek KD (2012) Deaths: Final data for 2010. Natl Vital Stat Rep 60: 1-68.
35. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL et al. (2004) Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65: 1357-1365. doi:10.1111/j.1523-1755.2004.00512.x. PubMed: 15086475. (Pubitemid 38406974)
36. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U et al. (1993) T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361: 79-82. doi:10.1038/361079a0. PubMed: 7678446. (Pubitemid 23020778)
37. Tiwari MM, Brock RW, Megyesi JK, Kaushal GP, Mayeux PR (2005) Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: Role of nitric oxide and caspases. Am J Physiol Renal Physiol 289: F1324-F1332. PubMed: 15998845. (Pubitemid 41681367)
38. Kamimoto M, Mizuno S, Matsumoto K, Nakamura T (2009) Hepatocyte growth factor prevents multiple organ injuries in endotoxemic mice through a heme oxygenase-1-dependent mechanism. Biochem Biophys Res Commun 380: 333-337. doi:10.1016/j.bbrc.2009.01.080. PubMed: 19171123.
39. Kamimoto M, Mizuno S, Nakamura T (2009) Reciprocal regulation of IL-6 and IL-10 balance by hgf via recruitment of heme oxygenase-1 in macrophages for attenuation of liver injury in a mouse model of endotoxemia. Int J Mol Med 24: 161-170. PubMed: 19578789.
40. Hamada J, Sawamura Y, Van Meir EG (1998) CD44 expression and growth factors. Front Biosci 3: d657-d664. PubMed: 9634542.
41. Herishanu Y, Gibellini F, Njuguna N, Hazan-Halevy I, Farooqui M et al. (2011) Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1. Leuk Lymphoma 52: 1758-1769. PubMed: 21649540.
42. Zheng YH, Tian C, Meng Y, Qin YW, Du YH et al. (2012) Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. J Cell Physiol 227: 127-135. doi:10.1002/jcp. 22709. PubMed: 21374592.
43. Chen BC, Lin WW (2001) PKC- and ERK-dependent activation of IκB kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor-mediated CaMK activation. Br J Pharmacol 134: 1055-1065. doi:10.1038/sj.bjp.0704334. PubMed: 11682454.
44. Scott MJ, Billiar TR (2008) Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes. J Biol Chem 283: 29433-29446. doi:10.1074/jbc.M803905200. PubMed: 18701460.
45. Kawana H, Karaki H, Higashi M, Miyazaki M, Hilberg F et al. (2008) CD44 suppresses TLR-mediated inflammation. J Immunol 180: 4235-4245. PubMed: 18322236.
46. Muto J, Yamasaki K, Taylor KR, Gallo RL (2009) Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol 47: 449-456. doi:10.1016/j.molimm.2009.08.026. PubMed: 19781786.